tradingkey.logo

Universe Pharmaceuticals Inc

UPC
查看詳細走勢圖
4.290USD
+0.560+15.01%
收盤 12/24, 13:00美東報價延遲15分鐘
2.42M總市值
0.00本益比TTM

Universe Pharmaceuticals Inc

4.290
+0.560+15.01%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+15.01%

5天

+16.58%

1月

+25.07%

6月

+18.84%

今年開始到現在

-82.42%

1年

-83.08%

查看詳細走勢圖

TradingKey Universe Pharmaceuticals Inc股票評分

單位: USD 更新時間: 2025-10-27

操作建議

當前估值低估,機構持股佔比非常低,目前股價在壓力位和支撐位之間,可以做區間波段操作。

Universe Pharmaceuticals Inc評分

相關信息

行業排名
140 / 173
全市場排名
621 / 4682
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 0 分析師
--
評級
--
目標均價
--
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Universe Pharmaceuticals Inc亮點

亮點風險
Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.
業績增長期
公司處於發展階段,最新年度總收入23.02M美元
估值高估
公司最新PE估值0.00,處於3年歷史高位
機構減倉
最新機構持股0.00股,環比減少100.00%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉0.00股

Universe Pharmaceuticals Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Universe Pharmaceuticals Inc簡介

Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.
公司代碼UPC
公司Universe Pharmaceuticals Inc
CEOLai (Gang)
網址http://www.universe-pharmacy.com/

常見問題

Universe Pharmaceuticals Inc(UPC)的當前股價是多少?

Universe Pharmaceuticals Inc(UPC)的當前股價是 4.290。

Universe Pharmaceuticals Inc 的股票代碼是什麼?

Universe Pharmaceuticals Inc的股票代碼是UPC。

Universe Pharmaceuticals Inc股票的52週最高點是多少?

Universe Pharmaceuticals Inc股票的52週最高點是28.000。

Universe Pharmaceuticals Inc股票的52週最低點是多少?

Universe Pharmaceuticals Inc股票的52週最低點是2.510。

Universe Pharmaceuticals Inc的市值是多少?

Universe Pharmaceuticals Inc的市值是2.42M。

Universe Pharmaceuticals Inc的淨利潤是多少?

Universe Pharmaceuticals Inc的淨利潤為-8.73M。

現在Universe Pharmaceuticals Inc(UPC)的股票是買入、持有還是賣出?

根據分析師評級,Universe Pharmaceuticals Inc(UPC)的總體評級為--,目標價格為--。

Universe Pharmaceuticals Inc(UPC)股票的每股收益(EPS TTM)是多少

Universe Pharmaceuticals Inc(UPC)股票的每股收益(EPS TTM)是1519.635。
KeyAI